Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion type Assertion NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_head.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion description "[Endocrine therapies that inhibit estrogen receptor (ER)-? signaling are the most common and effective treatment for ER-?-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_provenance.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion evidence source_evidence_literature NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_provenance.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion SIO_000772 22158035 NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_provenance.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion wasDerivedFrom befree-2016 NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_provenance.
- NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_assertion wasGeneratedBy ECO_0000203 NP945577.RAlOLCV4Okn3VPplG3TLszJXsbt5tXmmHz5ys-YqfwLe8130_provenance.